TY  - GEN
AU  - Nash,Richard A
AU  - Dansey,Roger
AU  - Storek,Jan
AU  - Georges,George E
AU  - Bowen,James D
AU  - Holmberg,Leona A
AU  - Kraft,George H
AU  - Mayes,Maureen D
AU  - McDonagh,Kevin T
AU  - Chen,Chien-Shing
AU  - Dipersio,John
AU  - Lemaistre,C Fred
AU  - Pavletic,Steven
AU  - Sullivan,Keith M
AU  - Sunderhaus,Julie
AU  - Furst,Daniel E
AU  - McSweeney,Peter A
TI  - Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases
SN  - 1083-8791
PY  - 2004///0609
KW  - Adult
KW  - Animals
KW  - Antigens, CD
KW  - analysis
KW  - Antigens, CD34
KW  - Antilymphocyte Serum
KW  - adverse effects
KW  - Autoimmune Diseases
KW  - therapy
KW  - B-Lymphocytes
KW  - chemistry
KW  - Blood Component Removal
KW  - Epstein-Barr Virus Infections
KW  - etiology
KW  - Female
KW  - Flow Cytometry
KW  - Granulocyte Colony-Stimulating Factor
KW  - pharmacology
KW  - Herpesvirus 4, Human
KW  - isolation & purification
KW  - Horses
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Killer Cells, Natural
KW  - Lymphoproliferative Disorders
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis
KW  - Neutrophils
KW  - Opportunistic Infections
KW  - Peripheral Blood Stem Cell Transplantation
KW  - Platelet Transfusion
KW  - Rabbits
KW  - Scleroderma, Systemic
KW  - T-Lymphocytes
KW  - Transplantation Conditioning
KW  - Transplantation, Autologous
N1  - Publication Type: Case Reports; Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/s1083-8791(03)00228-3
ER  -